EAM
KRTX

Eagle Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Eagle Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-178,849
Closed -$56.6M – 628
2023
Q4 		$56.6M Sell
178,849
-26,930
-13% -$5.23M 0.3% 116
2023
Q3 		$34.8M Sell
205,779
-681
-0.3% -$128K 0.21% 139
2023
Q2 		$44.8M Buy
206,460
+121,630
+143% +$26.1M 0.25% 130
2023
Q1 		$15.4M Sell
84,830
-31,109
-27% -$5.95M 0.09% 193
2022
Q4 		$22.4M Sell
115,939
-4,370
-4% -$937K 0.14% 161
2022
Q3 		$27.1M Sell
120,309
-5,133
-4% -$1.04M 0.18% 147
2022
Q2 		$15.9M Sell
125,442
-104,831
-46% -$12M 0.1% 198
2022
Q1 		$29.2M Sell
230,273
-12,497
-5% -$1.41M 0.15% 166
2021
Q4 		$31.6M Sell
242,770
-11,450
-5% -$1.48M 0.14% 177
2021
Q3 		$31.1M Sell
254,220
-21,506
-8% -$2.48M 0.14% 181
2021
Q2 		$31.4M Sell
275,726
-10,041
-4% -$1.17M 0.13% 197
2021
Q1 		$35.1M Buy
285,767
+18,360
+7% +$2.08M 0.16% 193
2020
Q4 		$27.2M Sell
267,407
-26,651
-9% -$2.47M 0.15% 195
2020
Q3 		$23.2M Buy
294,058
+6,008
+2% +$512K 0.12% 203
2020
Q2 		$30.6M Buy
288,050
+178,223
+162% +$15.5M 0.17% 180
2020
Q1 		$7.91M Buy
109,827
+14,390
+15% +$1.23M 0.05% 305
2019
Q4 		$7.19M Buy
+95,437
New +$4.18M 0.03% 356

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Eagle Asset Management's KRTX Position: Q1 2024 in Review

Eagle Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 178,849 shares — an estimated $56.6M sold.

Eagle Asset Management first reported a position in KRTX in Q4 2019 and held it in 17 quarters. The position peaked at $56.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Eagle Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 178,849 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $56.6M.
  • Eagle Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Eagle Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $56.6M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.